ARS Pharmaceuticals, Inc. — Investor Relations & Filings
Filings indexed
491
across all filing types
Latest filing
2026-05-15
Interim / Quarterly Rep…
Country
US
United States of America
Listing
US
SPRY
ARS Pharmaceuticals, Inc. is a biopharmaceutical company focused on the development and commercialization of innovative, needle-free products for administering therapies. The company's lead product is neffy (epinephrine nasal spray), the first and only FDA-approved needle-free treatment for severe allergic reactions (Type I hypersensitivity), including anaphylaxis. Developed as a patient-friendly alternative to auto-injectors, neffy is designed to be easy to carry and use, addressing challenges such as needle-related risks and hesitation in administration for both patients and caregivers.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 10-Q | 2026-05-15 | English | |
| 8-K | 2026-05-15 | English | |
| 8-K - ARS Pharmaceuticals, Inc. (0001671858) (Filer) | 2026-05-13 | English | |
| Director's Dealing 2026 | 2026-01-05 | English | |
| Director's Dealing 2026 | 2026-01-05 | English | |
| Director's Dealing 2026 | 2026-01-05 | English |
Browse filings by year
10 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
10 filings
| |||||
| 46351960 | 10-Q | 2026-05-15 | English | ||
| 46352424 | 8-K | 2026-05-15 | English | ||
| 45583446 | 8-K - ARS Pharmaceuticals, Inc. (0001671858) (Filer) | 2026-05-13 | English | ||
| 12948737 | Director's Dealing 2026 | 2026-01-05 | English | ||
| 12948739 | Director's Dealing 2026 | 2026-01-05 | English | ||
| 12948740 | Director's Dealing 2026 | 2026-01-05 | English | ||
| 12948741 | Director's Dealing 2026 | 2026-01-05 | English | ||
| 12948742 | Director's Dealing 2026 | 2026-01-05 | English | ||
| 12948743 | Director's Dealing 2026 | 2026-01-05 | English | ||
| 12948744 | Director's Dealing 2026 | 2026-01-05 | English | ||
|
2025
5 filings
| |||||
| 12948745 | Director's Dealing 2025 | 2025-11-15 | English | ||
| 12948746 | Director's Dealing 2025 | 2025-11-15 | English | ||
| 12948747 | Director's Dealing 2025 | 2025-11-15 | English | ||
| 12948748 | Regulatory Filings 2025 | 2025-11-13 | English | ||
| 12948749 | Regulatory Filings 2025 | 2025-11-12 | English | ||
Market data
Market data not available
Last price
Market cap
volume
Day range
today
52-week range
trailing
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
Avagenesis Corp.
Develops automated technology for isolating and enriching r…
|
VVA | CA | Manufacturing |
|
Avalon GloboCare Corp.
Develops cell-based immunotherapies and provides precision …
|
ALBT | US | Manufacturing |
|
AVECHO BIOTECHNOLOGY LIMITED
Develops human and animal health products using TPM® drug d…
|
AVE | AU | Manufacturing |
|
Avicanna Inc.
Commercial-stage international biopharma focused on evidenc…
|
AVCN | CA | Manufacturing |
|
Avidity Biosciences, Inc.
Develops a class of RNA therapeutics called Antibody Oligon…
|
RNA | US | Manufacturing |
|
Avivagen Inc.
Developed natural health products and feed additives; filed…
|
VIV | CA | Manufacturing |
|
Awakn Life Sciences Corp. (1169082 BC Ltd.)
Clinical-stage biotech developing novel therapeutics, inclu…
|
AWKN | CA | Manufacturing |
|
Axcan Pharma Inc.
Specialty pharmaceutical company focused on prescription th…
|
AXCA | CA | Manufacturing |
|
Axogen, Inc.
Develops and commercializes surgical solutions for peripher…
|
AXGN | US | Manufacturing |
|
Axsome Therapeutics, Inc.
A biopharmaceutical company developing therapies for centra…
|
AXSM | US | Manufacturing |
ARS Pharmaceuticals, Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/32159/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=32159 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=32159 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
Full reference: API reference · OpenAPI schema
cURL
$ curl https://api.financialreports.eu/api/filings/?company=32159 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 32159}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for ARS Pharmaceuticals, Inc. (id: 32159)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.
We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.